Related Experiment Video

Updated: Jul 11, 2026

Production and Detection of Reactive Oxygen Species (ROS) in Cancers
07:17

Production and Detection of Reactive Oxygen Species (ROS) in Cancers

Published on: November 21, 2011

NO Pain! No Cancer? The Crosstalk Between Nociception, ROS, and Cancer Development

Tzu-Yin Chen1, Tohru Yoshioka2, Wen-Li Hsu1,2

  • 1National Center for Geriatrics and Welfare Research, National Health Research Institutes, 632007 Yunlin, Taiwan.

Frontiers in Bioscience (Landmark Edition)
|March 28, 2025
PubMed

Insights

Targeting nociceptive Transient Receptor Potential (TRP) channels and their link to reactive oxygen species (ROS) may treat cancer and pain. This approach addresses shared pathways in carcinogenesis and nociception.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Transient Receptor Potential (TRP) channels are crucial in pain signaling and cancer development.
  • Activation of nociceptive TRP channels leads to calcium influx, oxidative stress, and reactive oxygen species (ROS) accumulation.

Purpose of the Study:

  • To explore the link between nociceptive TRP channels, ROS, and their dual role in pain and cancer.
  • To propose a therapeutic strategy targeting the crosstalk between TRP channels and ROS.

Main Methods:

  • Literature review and analysis of existing research on TRP channels, ROS, pain, and cancer.
  • Conceptual framework development for therapeutic intervention.

Main Results:

  • ROS production driven by TRP channel activation contributes to both pain signaling and genomic instability, a hallmark of cancer.
  • A correlation between pain and cancer onset is suggested by the shared involvement of nociceptive TRP channels.

Conclusions:

  • Targeting the interaction between nociceptive TRP channels and ROS presents a promising strategy for simultaneously managing cancer and associated pain.
  • Further research is warranted to confirm the causal link and optimize therapeutic interventions.
Keywords:
ROScancer progressionmitochondrial Canociceptive transient receptor potential channelpain

More Related Videos

Teasing Out the Interplay Between Natural Killer Cells and Nociceptor Neurons09:40

Teasing Out the Interplay Between Natural Killer Cells and Nociceptor Neurons

Published on: June 30, 2022

Establishing In Vitro Models of Dorsal Root Ganglia Culture: Complementary Approaches for Investigating Cancer-Nerve Crosstalk11:26

Establishing In Vitro Models of Dorsal Root Ganglia Culture: Complementary Approaches for Investigating Cancer-Nerve Crosstalk

Published on: July 11, 2025

Related Concept Videos

Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...